These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 687671

  • 1. Potentiating action of 5-fluorouracil when used in combination with platinium compounds and cyclophosphamide in treatment of advanced L1210 leukemia.
    Gale GR, Atkins LM, Schwartz P, Meischen SJ.
    Bioinorg Chem; 1978; 8(5):445-51. PubMed ID: 687671
    [Abstract] [Full Text] [Related]

  • 2. Synergistic action of high-dose hydroxyurea when used with cyclophosphamide and certain new organoplatinum complexes in treatment of advanced L1210 leukemia.
    Gale GR, Atkins LM, Meischen SJ, Schwartz P.
    Cancer; 1978 Apr; 41(4):1230-4. PubMed ID: 638988
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
    Glae GR, Atkins LM, Meischen SJ, Smith AB, Walker EM.
    J Natl Cancer Inst; 1976 Dec; 57(6):1363-6. PubMed ID: 187805
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR, Atkins LM, Meischen SJ, Smith AB, Walker EM.
    Cancer Treat Rep; 1977 Dec; 61(3):445-50. PubMed ID: 872142
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
    Wampler GL, Carter WH, Campbell ED.
    Cancer Invest; 1987 Dec; 5(6):523-33. PubMed ID: 3442730
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytotoxic effect of 5-fluorouracil plus cyclophosphamide against transplantable leukemias.
    Santelli G, Valeriote F, Vietti T, Coulter D.
    Eur J Cancer (1965); 1981 Jun; 17(6):629-34. PubMed ID: 7308260
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictive values of the in vivo diffusion chamber for cyclophosphamide treatment of L1210 murine leukemia.
    Anderson KC, Humphrey RL, Sensenbrenner LL.
    Cancer Res; 1983 May; 43(5):2030-3. PubMed ID: 6831434
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.